Skip to main content
JAMA internal medicine
Hospital admissions for hypoglycemia now exceed those for hyperglycemia in Medicare beneficiaries.
Developing methods for less is more.
Assessing the safety and effectiveness of devices after US Food and Drug Administration approval: FDA-mandated postapproval studies.
The importance of postapproval data for dabigatran.
A new program for sharing medical cost information.
Cardiac patient outcomes during national cardiology meetings.
Stress testing in the emergency department: not which test but whether any test should be done.
Advancing medical professionalism and the choosing wisely campaign--reply.
Time for professional societies to be bold and wise.
